Showing results (701-710 of 790) with videos related to
Sort By:
Pageof 79
Journal of Clinical Microbiology|September 3, 2010
Cholera toxin production by the El Tor variant of Vibrio cholerae O1 compared to prototype El Tor and classical biotypesJ Ghosh-Banerjee, M Senoh, T Takahashi, et al.Nanomaterials (Basel, Switzerland)|December 11, 2022
Formulation, Characterization, Anti-Inflammatory and Cytotoxicity Study of Sesamol-Laden NanospongesAnroop B Nair, Pooja Dalal, Varsha Kadian, et al.Epidemiology and Infection|July 31, 2010
Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slumD Sur, B Manna, S K Niyogi, et al.Journal of Bacteriology|May 16, 2000
Distinctiveness of genotypes of Helicobacter pylori in Calcutta, IndiaA K Mukhopadhyay, D Kersulyte, J Y Jeong, et al.The Journal of Infection|July 1, 1995
Epidemiology of Vibrio cholerae O139 with special reference to intrafamilial transmission in CalcuttaP G Sengupta, B K Sircar, S K Mandal, et al.Nature Materials|March 22, 2024
Highly reversible extrinsic electrocaloric effects over a wide temperature range in epitaxially strained SrTiO<sub>3</sub> filmsS Zhang, J Deliyore-Ramírez, S Deng, et al.Current HIV Research|April 30, 2010
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticlesSupriya D Mahajan, Indrajit Roy, Gaixia Xu, et al.Journal of Clinical Microbiology|February 22, 2008
Prevalence of virulence genes and cytolethal distending toxin production in Campylobacter jejuni isolates from diarrheal patients in BangladeshKaisar A Talukder, Mohammad Aslam, Zhahirul Islam, et al.Materials (Basel, Switzerland)|November 13, 2021
Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity StudiesMansi Bhanderi, Jigar Shah, Bapi Gorain, et al.Molecules (Basel, Switzerland)|December 19, 2019
Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular CarcinomaAnroop B Nair, Jigar Shah, Bandar E Al-Dhubiab, et al.Pageof 79